MedPath

Randomized controlled study of Liuwei Dihuang capsule in the treatment of yin deficiency syndrome of Alzheimer's disease

Phase 1
Recruiting
Conditions
Alzheimer disease
Registration Number
ITMCTR2100004335
Lead Sponsor
Traditional Chinese Pharmacological Laboratory, School of Traditional Chinese Medicine, Southern Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Aged 50-85 years;
(2) According to the core clinical diagnostic criteria of Alzheimer's disease dementia (2011) of National Institute on aging and Alzheimer's Association (nia-aa) or mild cognitive impairment caused by Alzheimer's disease (2011); according to the diagnostic scale of yin deficiency syndrome of Alzheimer's disease, it was judged as yin deficiency syndrome; the course of memory loss was more than 6 months and confirmed by others The possible manifestations of AD (asymmetric atrophy of medial temporal lobe or hippocampus, etc.) were found on MRI scan;
(3) Graduated from primary school or above, able to complete relevant tests and inspections;
(4) The patients with mild and moderate condition: the total score of mini mental state examination >= 11 and < 27; the total score of clinical dementia rating scale >= 0.5 and <= 2; the total score of haginsky ischemia scale <= 4;
(5) There are stable and reliable caregivers; voluntary and legal guardians agree to participate, and jointly sign the informed consent.

Exclusion Criteria

(1) Dementia caused by other reasons;
(2) severe cardiovascular system, respiratory system, digestive system, endocrine system, severe liver and kidney dysfunction;
(3) Those who are definitely diagnosed with depression, anxiety and other mental diseases or are taking anti anxiety and depression drugs; take other traditional Chinese medicine containing experimental traditional Chinese medicine ingredients within one month;
(4) Other situations that the researchers think are not suitable to participate in this study.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.